Jim Simons Intercept Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $535,464 - $1 Million	-53,600 Reduced 6.1%	825,800 $15.3 Million
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $1.57 Million - $3.29 Million	-170,800 Reduced 16.26%	879,400 $9.73 Million
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $4.28 Million - $7.42 Million	341,900 Added 48.27%	1,050,200 $14.1 Million
Q4 2022 Feb 13, 2023	SELL	$11.61 - $16.11 $358,749 - $497,799	-30,900 Reduced 4.18%	708,300 $8.76 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $4.22 Million - $6.81 Million	345,800 Added 87.9%	739,200 $10.3 Million

Q2 2022 Aug 12, 2022	BUY	$11.23 - $19.59 $2 Million - $3.49 Million	178,200 Added 82.81%	393,400 $5.43 Million
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $379,293 - $504,684	-28,369 Reduced 11.65%	215,200 $3.5 Million
Q4 2021 Feb 11, 2022	BUY	$14.28 - $19.53 $627,877 - $858,714	43,969 Added 22.03%	243,569 $3.97 Million
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $2.59 Million - $4.09 Million	199,600 New	199,600 $2.96 Million
Q2 2021 Aug 13, 2021	SELL	$15.46 - $24.5 $550,376 - $872,200	-35,600 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $7.76 Million - $15.2 Million	-401,400 Reduced 91.85%	35,600 $822,000
Q4 2020 Feb 10, 2021	BUY	$24.48 - $42.47 $4.71 Million - $8.17 Million	192,300 Added 78.59%	437,000 $10.8 Million
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $2.95 Million - $4.03 Million	-75,500 Reduced 23.58%	244,700 $10.1 Million
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $644,460 - $1.27 Million	13,800 Added 4.5%	320,200 $15.3 Million
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $10.4 Million - $25.4 Million	214,200 Added 232.32%	306,400 $19.3 Million
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $5.29 Million - $11.4 Million	92,200 New	92,200 $11.4 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account